Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169: 626-32.
Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90:3215-24.
Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, Maalouf G, et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis:an international epidemiological investigation. J Intern Med 2006; 260:245-54.
Orwoll E, Nielson CM, Marshall LM, Lambert L, Holton KF, Hoffman AR, et al.; Osteoporotic Fractures in Men (MrOS) Study Group. Vitamin D deficiency in older men. J Clin Endocrinol Metab 2009; 94: 1214-22.
Florentin M, Elisaf MS, Mikhailidis DP, Liberopoulos EN. Vitamin D and metabolic syndrome: is there a link? Curr Pharm Des 2010; 16: 3417-34.
Boucher BJ. Vitamin D insufficiency and diabetes risks. Curr Drug Targets 2011; 12: 61-87.
Pilz S, Tomaschitz A, Ritz E, Pieber TR. Vitamin D status and arterial hypertension:a systematic review. Nat Rev Cardiol 2009; 6: 621-30.
Reddy Vanga S, Good M, Howard PA, Vacek JL. Role of vitamin D in cardiovascular health. Am J Cardiol 2010; 106: 798-805.
Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168: 1340-9.
Vigna L, Silvia Tirelli A, Grossi E, Turolo S, Tomaino L, Napolitano F, et al. Directional relationship between vitamin D status and prediabetes: a new approach from artificial neural network in a cohort of workers with overweightobesity. J Am Coll Nutr 2019; 38: 681-92.
Korean Diabetes Association; Korea Centers for Disease Control and Prevention. Diabetes fact sheet in Korea 2012. Seoul: Korean Diabetes Association;2012.
Verdoia M, Schaffer A, Cassetti E, Barbieri L, Di Ruocco MV, Perrone-Filardi P, et al.; Novara Atherosclerosis Study Group (NAS). Glycosylatedhemoglobin and coronary artery disease in patients without diabetes mellitus. Am J Prev Med 2014; 47: 9-16.
Kim D, Kim J. Age and sex differences in the relationship between serum 25-hydroxyvitamin D and hypertension in the general Korean population. Eur J Clin Nutr 2016; 70: 326-32.
Gupta AK, Brashear MM, Johnson WD. Prediabetes and prehypertension in healthy adults are associated with low vitamin D levels. Diabetes Care 2011; 34: 658-60.
Arora P, Song Y, Dusek J, Plotnikoff G, Sabatine MS, Cheng S, et al. Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial. Circulation 2015; 131: 254-62.
Gupta AK, Brashear MM, Johnson WD. Low vitamin D levels, prediabetes and prehypertension in healthy African American adults. Nutr Metab Cardiovasc Dis 2012; 22: 877-82.
Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81.
Knekt P, Laaksonen M, Mattila C, Härkänen T, Marniemi J, Heliövaara M, et al. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008; 19: 666-71.
Forouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, Langenberg C, et al. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes:results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies. Diabetologia 2012; 55: 2173-82.
Tuomainen TP, Virtanen JK, Voutilainen S, Nurmi T, Mursu J, de Mello VD, et al. Glucose metabolism effects of vitamin D in prediabetes: the vitDmet randomized placebo-controlled supplementation study. J Diabetes Res 2015; 2015: 672653.
Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009; 94:26-34.
Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension 2010; 55:1283-8.
Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-38.
Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 2011; 29: 636-45.
Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49: 1063-9.
Chan R, Chan D, Woo J, Ohlsson C, Mellström D, Kwok T, et al. Serum 25-hydroxyvitamin D and parathyroid hormone levels in relation to blood pressure in a cross-sectional study in older Chinese men. J Hum Hypertens 2012; 26: 20-7.